4//SEC Filing
Lorianne Masuoka K. 4
Accession 0001235802-24-000015
CIK 0001401040other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 4:23 PM ET
Size
6.2 KB
Accession
0001235802-24-000015
Insider Transaction Report
Form 4
Lorianne Masuoka K.
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2024-01-22+285,000→ 285,000 totalExercise: $2.79Exp: 2034-01-21→ Common Shares (285,000 underlying)
Holdings
- 0
Voting Common Shares, no par value per share
Footnotes (1)
- [F1]Vests with respect to 25% of the underlying common shares on January 22, 2025 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on April 1, 2025.
Documents
Issuer
DiaMedica Therapeutics Inc.
CIK 0001401040
Entity typeother
Related Parties
1- filerCIK 0001466086
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 4:23 PM ET
- Size
- 6.2 KB